These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32454036)

  • 1. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
    Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease.
    Sookoian S; Flichman D; Castaño GO; Pirola CJ
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1224-1234. PubMed ID: 27778410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
    Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol dehydrogenase-1B genotype (rs1229984) is a strong determinant of the relationship between body weight and alcohol intake in Japanese alcoholic men.
    Yokoyama A; Yokoyama T; Matsui T; Mizukami T; Matsushita S; Higuchi S; Maruyama K
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1123-32. PubMed ID: 23414439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
    Ferrari P; McKay JD; Jenab M; Brennan P; Canzian F; Vogel U; Tjønneland A; Overvad K; Tolstrup JS; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Boeing H; Bergmann M; Trichopoulou A; Katsoulis M; Trichopoulos D; Krogh V; Panico S; Sacerdote C; Palli D; Tumino R; Peeters PH; van Gils CH; Bueno-de-Mesquita B; Vrieling A; Lund E; Hjartåker A; Agudo A; Suarez LR; Arriola L; Chirlaque MD; Ardanaz E; Sánchez MJ; Manjer J; Lindkvist B; Hallmans G; Palmqvist R; Allen N; Key T; Khaw KT; Slimani N; Rinaldi S; Romieu I; Boffetta P; Romaguera D; Norat T; Riboli E
    Eur J Clin Nutr; 2012 Dec; 66(12):1303-8. PubMed ID: 23149980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
    Xanthakos SA; Jenkins TM; Kleiner DE; Boyce TW; Mourya R; Karns R; Brandt ML; Harmon CM; Helmrath MA; Michalsky MP; Courcoulas AP; Zeller MH; Inge TH;
    Gastroenterology; 2015 Sep; 149(3):623-34.e8. PubMed ID: 26026390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
    Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
    J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
    Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.
    Holmes MV; Dale CE; Zuccolo L; Silverwood RJ; Guo Y; Ye Z; Prieto-Merino D; Dehghan A; Trompet S; Wong A; Cavadino A; Drogan D; Padmanabhan S; Li S; Yesupriya A; Leusink M; Sundstrom J; Hubacek JA; Pikhart H; Swerdlow DI; Panayiotou AG; Borinskaya SA; Finan C; Shah S; Kuchenbaecker KB; Shah T; Engmann J; Folkersen L; Eriksson P; Ricceri F; Melander O; Sacerdote C; Gamble DM; Rayaprolu S; Ross OA; McLachlan S; Vikhireva O; Sluijs I; Scott RA; Adamkova V; Flicker L; Bockxmeer FM; Power C; Marques-Vidal P; Meade T; Marmot MG; Ferro JM; Paulos-Pinheiro S; Humphries SE; Talmud PJ; Mateo Leach I; Verweij N; Linneberg A; Skaaby T; Doevendans PA; Cramer MJ; van der Harst P; Klungel OH; Dowling NF; Dominiczak AF; Kumari M; Nicolaides AN; Weikert C; Boeing H; Ebrahim S; Gaunt TR; Price JF; Lannfelt L; Peasey A; Kubinova R; Pajak A; Malyutina S; Voevoda MI; Tamosiunas A; Maitland-van der Zee AH; Norman PE; Hankey GJ; Bergmann MM; Hofman A; Franco OH; Cooper J; Palmen J; Spiering W; de Jong PA; Kuh D; Hardy R; Uitterlinden AG; Ikram MA; Ford I; Hyppönen E; Almeida OP; Wareham NJ; Khaw KT; Hamsten A; Husemoen LL; Tjønneland A; Tolstrup JS; Rimm E; Beulens JW; Verschuren WM; Onland-Moret NC; Hofker MH; Wannamethee SG; Whincup PH; Morris R; Vicente AM; Watkins H; Farrall M; Jukema JW; Meschia J; Cupples LA; Sharp SJ; Fornage M; Kooperberg C; LaCroix AZ; Dai JY; Lanktree MB; Siscovick DS; Jorgenson E; Spring B; Coresh J; Li YR; Buxbaum SG; Schreiner PJ; Ellison RC; Tsai MY; Patel SR; Redline S; Johnson AD; Hoogeveen RC; Hakonarson H; Rotter JI; Boerwinkle E; de Bakker PI; Kivimaki M; Asselbergs FW; Sattar N; Lawlor DA; Whittaker J; Davey Smith G; Mukamal K; Psaty BM; Wilson JG; Lange LA; Hamidovic A; Hingorani AD; Nordestgaard BG; Bobak M; Leon DA; Langenberg C; Palmer TM; Reiner AP; Keating BJ; Dudbridge F; Casas JP;
    BMJ; 2014 Jul; 349():g4164. PubMed ID: 25011450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis.
    Li H; Toth E; Cherrington NJ
    Toxicol Sci; 2018 Aug; 164(2):428-438. PubMed ID: 29718361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol-metabolizing genes and alcohol phenotypes in an Israeli household sample.
    Meyers JL; Shmulewitz D; Aharonovich E; Waxman R; Frisch A; Weizman A; Spivak B; Edenberg HJ; Gelernter J; Hasin DS
    Alcohol Clin Exp Res; 2013 Nov; 37(11):1872-81. PubMed ID: 23895337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
    Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
    World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnicity and nonalcoholic fatty liver disease.
    Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
    Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphisms of Alcohol Metabolizing Enzymes and Alcohol Consumption are Associated With Asymptomatic Cardiac Remodeling and Subclinical Systolic Dysfunction in Large Community-Dwelling Asians.
    Hung CL; Chang SC; Chang SH; Chi PC; Lai YJ; Wang SW; Wu YJ; Yeh HI; Lin SJ; Chen CH; Mochly-Rosen D; Wang LY;
    Alcohol Alcohol; 2017 Nov; 52(6):638-646. PubMed ID: 29016726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations of aldehyde dehydrogenase 2 and alcohol dehydrogenase 1B are associated with the etiology of atrial fibrillation in Japanese.
    Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Matsumura H; Tomomori S; Amioka M; Hironomobe N; Motoda C; Oda N; Chayama K; Chen CH; Gross ER; Mochly-Rosen D; Kihara Y
    J Biomed Sci; 2016 Dec; 23(1):89. PubMed ID: 27927211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol consumption mediates the relationship between ADH1B and DSM-IV alcohol use disorder and criteria.
    Kilcoyne B; Shmulewitz D; Meyers JL; Aharonovich E; Greenstein E; Frisch A; Weizman A; Spivak B; Edenberg HJ; Gelernter J; Hasin DS
    J Stud Alcohol Drugs; 2014 Jul; 75(4):635-42. PubMed ID: 24988262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
    World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
    Kistler KD; Brunt EM; Clark JM; Diehl AM; Sallis JF; Schwimmer JB;
    Am J Gastroenterol; 2011 Mar; 106(3):460-8; quiz 469. PubMed ID: 21206486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.